----

----

| Nevada                          | 80-0159248          |
|---------------------------------|---------------------|
| (State or other jurisdiction of | (I.R.S. Employer    |
| incorporation or organization)  | Identification No.) |

| Yes   x | No   o |
|------------------------|-----------------------|

| Yes   o | No   x |
|------------------------|-----------------------|

----

| Large accelerated filer o                     |   | Accelerated filer o         |
|-----------------------------------------------|--------|----------------------------------|
|                                          |   |                             |
| Non-accelerated filer o                       |   | Smaller reporting company x |
| (Do not check if a smaller reporting company) |   |                             |

| Yes   x | No   o |
|------------------------|-----------------------|

----

|                                                                                                                                                                                                                 |   | Page   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------|
| PART I - FINANCIAL INFORMATION                                                                                                                                                                                  |   |   |
|                                                                                                                                                                                                                 |   |   |
|         Item 1  Financial Statements:                                                                                                                                   |   | 4      |
|                                                                                                                                                                                                                 |   |   |
|         Balance Sheets as of  June 30, 2010 (unaudited) and March 31, 2010                                                                                         |   | 5      |
|                                                                                                                                                                                                                 |   |   |
|         Statements of Operations for the three months ended June 30, 2010 and 2009, and the period of March 13, 2008 (Inception) to June 30, 2010 (unaudited)           |   | 6      |
|                                                                                                                                                                                                                 |   |   |
|         Statements of Cash Flows for the three months ended June 30, 2010 and 2009, and the period of March 13, 2008 (Inception) to June 30, 2010 (unaudited) |   | 7      |
|                                                                                                                                                                                                                 |   |   |
|         Notes to Unaudited  Financial Statements                                                                                                                        |   | 8      |
|                                                                                                                                                                                                                 |   |   |
|         Item 2  Management’s Discussion and Analysis of Financial Condition and Results of Operations                                                             |   | 9      |
|                                                                                                                                                                                                                 |   |   |
|         Item 3  Quantitative and Qualitative Disclosures About Market Risk                                                                                              |   | 11     |
|                                                                                                                                                                                                                 |   |   |
|         Item 4T  Controls and Procedures                                                                                                                                |   | 11     |
|                                                                                                                                                                                                                 |   |   |
| PART II – OTHER INFORMATION                                                                                                                                                                                    |   |   |
|                                                                                                                                                                                                                 |   |   |
|         Item 1   Legal Proceedings                                                                                                                                 |   | 12     |
|                                                                                                                                                                                                                 |   |   |
|         Item 1A.  Risk Factors                                                                                                                                          |   | 13     |
|                                                                                                                                                                                                                 |   |   |
|         Item 2   Unregistered Sales of  Equity Securities and Use of Proceeds                                                                                 |   | 13     |
|                                                                                                                                                                                                                 |   |   |
|         Item 3   Defaults upon Senior Securities                                                                                                                   |   | 13     |
|                                                                                                                                                                                                                 |   |   |
|         Item 4   (Removed and Reserved)                                                                                                                       |   | 13     |
|                                                                                                                                                                                                                 |   |   |
|         Item 5  Other Information                                                                                                                                       |   | 13     |
|                                                                                                                                                                                                                 |   |   |
|         Item 6  Exhibits                                                                                                                                                |   | 13     |
|                                                                                                                                                                                                                 |   |   |
|         Signatures                                                                                                                                                           |   | 14     |

----

| Item 1. | Financial Statements. |
|---------|-----------------------|

----

| MEDISTAFF CORPORATION                                                                                                                                  |          |
|--------------------------------------------------------------------------------------------------------------------------------------------------------|---------------|
| (A Development Stage Enterprise)                                                                                                                       |          |
| Balance Sheets                                                                                                                                         |          |
|                                                                                                                                                   |          |   |   |   |   |   |
|                                                                                                                                                   | June 30, 2010 |   | March 31, 2010 |   |
|                                                                                                                                                   |
|                                                                                                                                                   | (Unaudited)   |   |   |   |   |
| ASSETS                                                                                                                                                 |          |
|                                                                                                                                                   |          |   |   |   |   |   |
| Current assets                                                                                                                                         |          |   |   |   |   |   |
| Cash                                                                                                                                                   |          | $ | 2,264 |   |   | $ | 3,366 |   |
| Total current assets                                                                                                                                   |          |   | 2,264 |   |   |   | 3,366 |   |
|                                                                                                                                                   |          |   |   |   |   |   |   |   |
| Total assets                                                                                                                                           |          | $ | 2,264 |   |   | $ | 3,366 |   |
|                                                                                                                                                   |          |   |   |   |   |   |   |   |
| LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)                                                                                                         |          |
|                                                                                                                                                   |          |   |   |   |   |   |   |   |
| Current liabilities                                                                                                                                    |          |   |   |   |   |   |   |   |
| Accounts payable and accrued liabilities                                                                                                               |          | $ | 4,850 |   |   | $ | 71 |   |
| Total current liabilities                                                                                                                              |          |   | 4,850 |   |   |   | 71 |   |
|                                                                                                                                                   |          |   |   |   |   |   |   |   |
| Stockholders' Equity (Deficit)                                                                                                                         |          |   |   |   |   |   |   |   |
| Common stock, $.001 par value; 75,000,000 shares authorized; 5,429,016 shares issued and outstanding at June 30, 2010 and March 31, 2010, respectively |          |   | 5,429 |   |   |   | 5,429 |   |
| Additional paid in capital                                                                                                                             |          |   | 35,846 |   |   |   | 35,846 |   |
| Deficit accumulated during the development stage                                                                                                       |          |   | (43,861 | ) |   |   | (37,980 | ) |
| Total stockholders' equity (deficit)                                                                                                                   |          |   | (2,586 | ) |   |   | 3,295 |   |
|                                                                                                                                                   |          |   |   |   |   |   |   |   |
| Total liabilities and stockholders' equity (deficit)                                                                                                   |          | $ | 2,264 |   |   | $ | 3,366 |   |
|                                                                                                                                                   |          |   |   |   |   |   |   |   |
| See accompanying notes to financial statements                                                                                                         |          |

----

| MEDISTAFF CORPORATION                          |   |
|------------------------------------------------|--------|
| (A Development Stage Enterprise)               |   |
| Statements of Operations (unaudited)      |   |
|                                           |   |
|                                           |   |   |   |   |   |   |   | Period from March 13, 2008 (inception) to June 30, 2010 |   |
|                                           |   |   |   |   |   |   |
|                                           |   | Three months endedJune 30, |   |
|                                           |   | 2010 |   |   | 2009 |   |
|                                           |   |   |   |   |   |   |   |   |   |
| Revenue                                        |   | $ | - |   |   | $ | - |   |   | $ | - |   |
|                                           |   |   |   |   |   |   |   |   |   |   |   |   |
| Operating expenses                             |   |   |   |   |   |   |   |   |   |   |   |   |
| Professional fees                              |   |   | 5,381 |   |   |   | 5,481 |   |   |   | 42,894 |   |
| Other general & administrative             |   |   | 500 |   |   |   | 106 |   |   |   | 975 |   |
| Total operating expenses                       |   |   | 5,881 |   |   |   | 5,587 |   |   |   | 43,869 |   |
|                                           |   |   |   |   |   |   |   |   |   |   |   |   |
| Other income (expense)                         |   |   |   |   |   |   |   |   |   |   |   |   |
| Interest expense                               |   |   | - |   |   |   | - |   |   |   | (90 | ) |
| Interest income                                |   |   | - |   |   |   | 2 |   |   |   | 8 |   |
| Other income                                   |   |   | - |   |   |   | 90 |   |   |   | 90 |   |
| Total other income (expense)                   |   |   | - |   |   |   | 92 |   |   |   | 8 |   |
|                                           |   |   |   |   |   |   |   |   |   |   |   |   |
| Net loss                                       |   | $ | (5,881 | ) |   | $ | (5,495 | ) |   | $ | (43,861 | ) |
|                                           |   |   |   |   |   |   |   |   |   |   |   |   |
| Basic and diluted loss per common share        |   | $ | (0.00 | ) |   | $ | (0.00 | ) |   |   |   |   |
|                                           |   |   |   |   |   |   |   |   |   |   |   |   |
| Weighted average shares outstanding            |   |   | 5,429,016 |   |   |   | 5,331,016 |   |   |   |   |   |
|                                           |   |   |   |   |   |   |   |   |   |   |   |   |
| See accompanying notes to financial statements |   |

----

| MEDISTAFF CORPORATION                                                      |                        |
|----------------------------------------------------------------------------|-----------------------------|
| (A Development Stage Enterprise)                                           |                        |
| Statements of Cash Flows (unaudited)                                       |                        |
|                                                                       |                        |
|                                                                       |                        |   |   |   |   |   | Period from March 13, 2008 (inception) to June 30, 2010 |   |
|                                                                       |                        |   |   |   |   |   |
|                                                                       |                        |   |   |   |   |   |
|                                                                       | Three months ended June 30, |   |
|                                                                       | 2010                        |   | 2009 |   |
| Cash flows from operating activities                                       |                        |   |   |   |   |   |   |
| Net loss                                                                   |                        | $ | (5,881 | ) |   | $ | (5,495 | ) |   | $ | (43,861 | ) |
| Adjustments to reconcile net loss to net cash used in operating activities |                        |
| Common stock issued for services                                           |                        |   | - |   |   |   | - |   |   |   | 1,375 |   |
| Changes in operating liabilities:                                          |                        |   |   |   |   |   |   |   |   |
| Increase in accounts payable                                               |                        |   | 4,779 |   |   |   | 2,391 |   |   |   | 4,850 |   |
| Net cash used in operating activities                                      |                        |   | (1,102 | ) |   |   | (3,104 | ) |   |   | (37,636 | ) |
|                                                                       |                        |   |   |   |   |   |   |   |   |   |   |   |
| Cash flows from investing activities                                       |                        |   | - |   |   |   | - |   |   |   | - |   |
|                                                                       |                        |   |   |   |   |   |   |   |   |   |   |   |
| Cash flows from financing activities                                       |                        |   |   |   |   |   |   |   |   |
| Proceeds from sale of common stock (net of offering costs)                 |                        |   | - |   |   |   | - |   |   |   | 39,900 |   |
| Net cash provided by financing activities                                  |                        |   | - |   |   |   | - |   |   |   | 39,900 |   |
|                                                                       |                        |   |   |   |   |   |   |   |   |   |   |   |
| Increase (decrease) in cash                                                |                        |   | (1,102 | ) |   |   | (3,104 | ) |   |   | 2,264 |   |
|                                                                       |                        |   |   |   |   |   |   |   |   |   |   |   |
| Cash at beginning of period                                                |                        |   | 3,366 |   |   |   | 13,055 |   |   |   | - |   |
|                                                                       |                        |   |   |   |   |   |   |   |   |   |   |   |
| Cash at end of period                                                      |                        | $ | 2,264 |   |   | $ | 9,951 |   |   | $ | 2,264 |   |
|                                                                       |                        |   |   |   |   |   |   |   |   |   |   |   |
| Supplemental cash flow Information:                                        |                        |   |   |   |   |   |   |   |   |
| Cash paid for interest                                                     |                        | $ | - |   |   | $ | - |   |   | $ | - |   |
| Cash paid for income taxes                                                 |                        | $ | - |   |   | $ | - |   |   | $ | - |   |
|                                                                       |                        |   |   |   |   |   |   |   |   |   |   |   |
| See accompanying notes to financial statements                             |                        |

----

----

| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations. |
|---------|----------------------------------------------------------------------------------------------|

|   | · | Hospitals and teaching facilities,              |
|--------|--------|-------------------------------------------------|
|   | · | Clinics and nursing homes, and                  |
|   | · | Organizations, such as corporations or schools. |

----

----

| Item 3. | Quantitative and Qualitative Disclosures about Market Risk. |
|---------|-------------------------------------------------------------|

| Item 4T. | Controls and Procedures |
|----------|-------------------------|

| (a) | Evaluation of Disclosure Controls and Procedures |
|-----|--------------------------------------------------|

----

|      ● | The Company’s Audit Committee does not function as an Audit Committee should, since there is a lack of independent directors on the Committee and the Board of Directors has not identified an “expert,” one who is knowledgeable about reporting and financial statements requirements, to serve on the Audit Committee. |
|----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|      ● | The Company has limited segregation of duties which is not consistent with good internal control procedures. |
|----------------------------------|--------------------------------------------------------------------------------------------------------------|

|      ● | The Company does not have a written internal control procedures manual that outlines the duties and reporting requirements of the Directors and any staff to be hired in the future.  This lack of a written internal control procedures manual does not meet the requirements of the SEC or good internal control. |
|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|      ● | There are no effective controls instituted over financial disclosure and the reporting processes. |
|----------------------------------|---------------------------------------------------------------------------------------------------|

| (b) | Changes in Internal Controls |
|-----|------------------------------|

| Item 1. | Legal Proceedings. |
|---------|--------------------|

----

|  Item 1A. | Risk Factors. |
|----------------|---------------|

| Item 2. | Unregistered Sales of Equity Securities and use of Proceeds |
|---------|-------------------------------------------------------------|

| Item 3. | Defaults upon Senior Securities. |
|---------|----------------------------------|

| Item 4. | (Removed and Reserved) |
|---------|------------------------|

| Item 5. | Other Information. |
|---------|--------------------|

| Item 6. | Exhibits. |
|---------|-----------|
|    |      |

|   | (a)    | Exhibits furnished as Exhibits hereto: |
|--------|--------|----------------------------------------|
|   |   |

| Exhibit No. | Description |
|-------------|-------------|

| 31.1 |   | 8650 SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER |
|------|--------|---------------------------------------------------------------------------------------|

| 32.1 |   | CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  |
|------|--------|-----------------------------------------------------------------------------------------------------------------------------|

----

|                | MediStaff  Corporation |
|---------------------|----------------------------------|
|                |                             |   |
| Date: July 26, 2010 | By:                              | /s/ Dale Byers     |
|                |                             | Dale Byers |
|                |                             | Chief Financial Officer and Treasurer |
|                |                             | (principal financial and accounting officer) |
|                |                             |   |
| Date: July 26, 2010 | By:                              | /s/ Dale Byers     |
|                |                             | Dale Byers |
|                |                             | President and Chief Executive Officer |

----